PT - JOURNAL ARTICLE AU - Moore, Anni AU - Venkatesh, Rasika AU - Levin, Michael G. AU - Damrauer, Scott M. AU - Reza, Nosheen AU - Cappola, Thomas P. AU - Ritchie, Marylyn D. TI - Connecting intermediate phenotypes to disease using multi-omics in heart failure AID - 10.1101/2024.08.06.24311572 DP - 2024 Jan 01 TA - medRxiv PG - 2024.08.06.24311572 4099 - http://medrxiv.org/content/early/2024/08/07/2024.08.06.24311572.short 4100 - http://medrxiv.org/content/early/2024/08/07/2024.08.06.24311572.full AB - Heart failure (HF) is one of the most common, complex, heterogeneous diseases in the world, with over 1-3% of the global population living with the condition. Progression of HF can be tracked via MRI measures of structural and functional changes to the heart, namely left ventricle (LV), including ejection fraction, mass, end-diastolic volume, and LV end-systolic volume. Moreover, while genome-wide association studies (GWAS) have been a useful tool to identify candidate variants involved in HF risk, they lack crucial tissue-specific and mechanistic information which can be gained from incorporating additional data modalities. This study addresses this gap by incorporating transcriptome-wide and proteome-wide association studies (TWAS and PWAS) to gain insights into genetically-regulated changes in gene expression and protein abundance in precursors to HF measured using MRI-derived cardiac measures as well as full-stage all-cause HF. We identified several gene and protein overlaps between LV ejection fraction and end-systolic volume measures. Many of the overlaps identified in MRI-derived measurements through TWAS and PWAS appear to be shared with all-cause HF. We implicate many putative pathways relevant in HF associated with these genes and proteins via gene-set enrichment and protein-protein interaction network approaches. The results of this study (1) highlight the benefit of using multi-omics to better understand genetics and (2) provide novel insights as to how changes in heart structure and function may relate to HF.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported through the following grants from the National Institutes of Health (NIH): AG066833, HL169458Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Source data were available before the initiation of this study. Reference eQTL and pQTL data models from GTEx and ARIC are available through PredictDB. MRI cardiac trait summary statistics are available through study publication Pirruccello JP, et al. All-cause HF summary statistics are available at the request of the authors from Lee et al on medRxiv.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll reference data used are available online through GTEx and ARIC. All summary statistics are accessible through their original published studies. https://ritchielab.org/publications/supplementary-data/psb-2025/hfmultiomics